Sinclair Pharma (SPH)

 

SPH Share PerformanceMore

52 week high36.750 26/05/16
52 week low26.000 28/09/16
52 week change -1.750 (-4.96%)
4 week volume6,548,893 02/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

All resolutions passed at Sinclair Pharma AGM

Sinclair Pharma has announced that all resolutions put to its Annual General Meeting held earlier today were duly passed. ...

Result of AGM

RNS Number: 3989D Sinclair Pharma PLC 26 April 2017 Sinclair Pharma plc Result of AGM London, 26 April 2017 Sinclair Pharma plc (SPH.L), ("Sinclair") the international Aesthetics company, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed. For further information please contact: Sinclair Pharma plc Tel: +44 (0...

Broker Forecast - N+1 Singer issues a broker note on Sinclair IS Pharma PLC

N+1 Singer today reaffirms its buy investment rating on Sinclair IS Pharma PLC (LON:SPH) and cut its price target to 37p...

Annual Financial Report

RNS Number: 0809B Sinclair Pharma PLC 30 March 2017 Sinclair Pharma plc Publication of Annual Report and Accounts London , 30 March 2017 Sinclair Pharma plc ( SPH.L), ("Sinclair" or the "Company") the international aesthetics company, announces that its Annual Report and Accounts for the year ended 31 December 2016 is available at the Company's web...

Additional listing

RNS Number: 9549A Sinclair Pharma PLC 30 March 2017 Sinclair Pharma plc Additional listing London , 30 March 2017 Sinclair Pharma plc ( SPH.L), ("Sinclair" or the "Company") the international aesthetics company, announces that 1,570,510 new ordinary shares of 1p each (the "New Ordinary Shares") have been issued and allotted to Christophe Foucher, former ...

Hardman Research: Much more streamlined

RNS Number: 6702A Sinclair Pharma PLC 28 March 2017 Hardman Research: Much more streamlined Much more streamlined - During 2016, Sinclair has been transformed into a streamlined pure-play aesthetics company with a concentrated, highly competitive, portfolio of differentiated injectable products. Effective, longer-lasting, natural looking, minimally inva...

Sinclair Pharma appoints joint broker

Sinclair Pharma has confirmed the appointment of RBC Capital Markets to act as its joint broker alongside Peel Hunt, wit...

Appointment of Joint Broker

RNS Number: 6073A Sinclair Pharma PLC 27 March 2017 Sinclair Pharma plc Appointment of Joint Broker London, 27 March 2017 Sinclair Pharma plc (SPH.L), ("Sinclair") the international Aesthetics company, announces the appointment of RBC Capital Markets to act as its joint broker alongside Peel Hunt LLP, with immediate effect. For further information ple...

Fundamental DataMore

EPS-5.9
Dividend yield0 %

Equity Research (SPH)

hardman & co
Sinclair Pharma plc
28/03/2017
During 2016, Sinclair has been transformed into a streamlined pure-play aesthetics company with a concentrated, highly competitive, portfolio of differentiated injectable products. Effective, longer-...
hardman & co
Sinclair Pharma plc
08/11/2016
Sinclair has evolved into a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics products. These products target unmet clinical...

Latest discussion posts More

  • Research note

    Very good comprehensive research note posted under today's RNS. Worth a read for anyone with an interest in SPH, of which there appears to be very few. Chozza
    28-Mar-2017
    charlus
  • Volume

    Huge volume (over 9M) traded so far this morning, and price still rising. Lokks like others are anticipating good results tomorrow. GLA
    20-Mar-2017
    charlus
  • Re: Results too

    Cut and paste from official results?. Barcelona, 27th February, 2017.- Almirall, the global pharmaceutical company based in Barcelona, has posted its full-year 2016 results ...
    19-Mar-2017
    Ambiorix1

Users' HoldingsMore

Users who hold Sinclair Pharma also hold..
LLOYDS GRP.40%
BP22%
VODAFONE GRP.22%
BARCLAYS22%
GLAXOSMITHKLINE20%

Codes & Symbols

ISINGB0033856740
SymbolsSPH, LSE:SPH, SPH.L, SPH:LN, LON:SPH, XLON:SPH